“@pasperper: Involucrar a los pacientes en el uso de la medicación esencial para mejorar resultados y prevenir daños http://t.co/qMHnfRKlSU”
— Sano y salvo (@sanoysalvoblog) June 9, 2013
Evaluación de la adecuación del tratamiento farmacológico en pacientes pluripatológicos. Aten Primaria: http://t.co/DQwmIWyioH #SegPac
— Sano y salvo (@sanoysalvoblog) June 10, 2013
¿Cómo revisar la medicación en los pacientes pluripatológicos? Aten Primaria: http://t.co/7IYC8d019H #SegPac
— Sano y salvo (@sanoysalvoblog) June 10, 2013
El consumo sanitario inapropiado y la trivialización de la medicina. A. Segura y V. Giner en Aten Primaria: http://t.co/MLvqxxUokf #SegPac
— Sano y salvo (@sanoysalvoblog) June 10, 2013
(BMJ) Warning: austerity can seriously damage your health http://t.co/rBmxp7K448 #PtSafety
— Sano y salvo (@sanoysalvoblog) June 10, 2013
(BMJ) FDA panel advises easing restrictions on rosiglitazone http://t.co/u1Qf96G9SI #PtSafety
— Sano y salvo (@sanoysalvoblog) June 10, 2013
(BMJ) Incretin therapy: should adverse consequences have been anticipated? http://t.co/GKCnxMEmCK #PtSafety
— Sano y salvo (@sanoysalvoblog) June 10, 2013
(BMJ) Helping patients make sense of the risks of taking GLP-1 agonists http://t.co/ZLAuvu0Q9N by @vmontori #PtSafety
— Sano y salvo (@sanoysalvoblog) June 10, 2013
(BMJ) Incretins and risk of neoplasia http://t.co/Cj6cSgFHIY #PtSafety
— Sano y salvo (@sanoysalvoblog) June 10, 2013
(BMJ) Has pancreatic damage from glucagon suppressing diabetes drugs been underplayed? http://t.co/vkCKJjnQPT #PtSafety
— Sano y salvo (@sanoysalvoblog) June 10, 2013
En Francia, algunos comprimidos de furosemida 40 mg y de zopiclona 7,5 mg se parecen como dos gotas de agua http://t.co/XJXkmiFnKO #SegPac
— Sano y salvo (@sanoysalvoblog) June 10, 2013
(BMJ) Screening has not reduced deaths from breast cancer, study shows http://t.co/BmhHW31E1A #PtSafety
— Sano y salvo (@sanoysalvoblog) June 11, 2013
(BMJ) Potential harms of type 2 diabetes drugs have been ignored, finds BMJ investigation http://t.co/QyWlM7mQ46 #PtSafety
— Sano y salvo (@sanoysalvoblog) June 11, 2013
How can clinical practice guidelines be adapted to help shared decision making? http://t.co/ydOMgpAPuH
— BMJ Quality & Safety (@BMJ_Qual_Saf) June 9, 2013
(Thorax) Use of inhaled corticosteroids and the risk of tuberculosis http://t.co/oFL0QtGxDt #PtSafety
— Sano y salvo (@sanoysalvoblog) June 11, 2013
Uno de cada cinco medicamentos que toma la gente mayor es inadecuado http://t.co/o9GhqH77mX #SegPac
— Sano y salvo (@sanoysalvoblog) June 11, 2013
¿Control de la prescripción o control de la indicación? Algoritmos Corporativos de Decisión Terapéutica http://t.co/DkmyTCpYDl
— Sano y salvo (@sanoysalvoblog) June 12, 2013
“@AEMPSGOB: Problemas de suministro del medicamento Epanutin (fenitoína) http://t.co/lBVYV2og7u”
— Sano y salvo (@sanoysalvoblog) June 12, 2013
(NHS Choices) Diabetes drugs may be linked to pancreatic cancer http://t.co/LoKTw6ZTZM #PtSafety
— Sano y salvo (@sanoysalvoblog) June 12, 2013
(NPS Medicinewise) Duration of antibiotic therapy and resistance http://t.co/ywjDN5mCgf #PtSafety
— Sano y salvo (@sanoysalvoblog) June 12, 2013
(MHRA) Using herbal medicines safely http://t.co/a9m5w9uHPs #PtSafety
— Sano y salvo (@sanoysalvoblog) June 12, 2013
Evaluation of documented drug interactions and contraindications associated with herbs and dietary supplements http://t.co/PqqJ3Eh8tI
— Sano y salvo (@sanoysalvoblog) June 12, 2013
Los recortes en sanidad en España ponen vidas en riesgo, según un estudio http://t.co/vHXk5hj9bw #SegPac
— Sano y salvo (@sanoysalvoblog) June 13, 2013
(JAMA Intern Med) Valores objetivo en HTA: historia de un despropósito: http://t.co/56X35ldx0q vía @rincondesisifo #SegPac
— Sano y salvo (@sanoysalvoblog) June 13, 2013
MT @txemacoll Determinados medidores Coaguchek® pueden mostrar “error 6” en valores de INR muy elevados http://t.co/BBh0sbW3F5 #SegPac
— Sano y salvo (@sanoysalvoblog) June 13, 2013
Association Between Hypoglycemia and Dementia in a Biracial Cohort of Older Adults With Diabetes Mellitus http://t.co/ayOexw3Wza #PtSafety
— Sano y salvo (@sanoysalvoblog) June 13, 2013
Glucose Control in Older Adults With Diabetes Mellitus—More Harm Than Good? by Kasia Lipska and @vmontori http://t.co/nUzkIuFNxo #PtSafety
— Sano y salvo (@sanoysalvoblog) June 13, 2013
Acabo de notificar efecto adverso en https://t.co/UzTZUjvWq8: fenómeno de Raynaud por aclidinio #TWDrugWatch #RAM #NovedadesTerapeuticas
— Enrique Gavilán (@enriquegavilan) June 14, 2013
“@SIETES7: Nou butlletí de farmacovigilància: Ginecomàstia per medicaments http://t.co/rD30o99VMm”
— Sano y salvo (@sanoysalvoblog) June 14, 2013
Estudio demuestra alta prevalencia uso inadecuado de omeprazol en ancianos pluripatológicos polimedicados - http://t.co/dnKYJklr9C
— polimedlabs (@polimedlabs) June 13, 2013
(JAMA) Patients' Responsibility to Participate in Decision Making and Research http://t.co/eg6LQI4HyW #PtSafety
— Sano y salvo (@sanoysalvoblog) June 14, 2013
“@kevinmd: Stop prescribing benzodiazepines for anxiety http://t.co/bcYBsYrp6K” #PtSafety
— Sano y salvo (@sanoysalvoblog) June 14, 2013
“@EMA_News: PRAC recommends restricting the use of #codeine when used for pain relief in children: http://t.co/fF1d1EtrI2” #PtSafety
— Sano y salvo (@sanoysalvoblog) June 15, 2013
“@EMA_News: PRAC recommends the same cardiovascular precautions for #diclofenac as for selective COX-2 inhibitors: http://t.co/6GVcnb847e”
— Sano y salvo (@sanoysalvoblog) June 15, 2013
Publicado por Sano y salvo
No hay comentarios:
Publicar un comentario